Search
01/01/2023
Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort
Marra, G, Soria, F, Peretti, F, Oderda, M, Dariane, C, Timsit, MO, Branchereau, J, Hedli, O, Mesnard, B, Tilki, D, Olsburgh, J, Kulkarni, M, Kasivisvanathan, V, Lebacle, C, Rodriguez-Faba, O, Breda, A, Soeterik, T, Gandaglia, G, Todeschini, P, Biancone, L, Gontero, P. Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort. Cancers. 2023; 15(1)DOI:10.3390/cancers15010189. PMID:36612184. IF:4.500(Q1/3D).
01/01/2023
Reduced- vs full-dose BCG in bladder cancer: a systematic review and meta-analysis
Verri P., Baboudjian M., Diana P., Gallioli A., Territo A., Gaya J.M., Huguet J., Rodriguez-Faba O., Palou J., Breda A.. Reduced- vs full-dose BCG in bladder cancer: a systematic review and meta-analysis. Actas Urologicas Espanolas. 2023; 47(1)DOI:10.1016/j.acuro.2022.06.001. PMID:37078844. IF:1.200(Q3/8D).
01/01/2023
The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery
Bravi C.A., Rosiello G., Mazzone E., Minervini A., Mari A., Di Maida F., Bensalah K., Peyronnet B., Khene Z.-E., Schiavina R., Bianchi L., Mottrie A., De Naeyer G., Antonelli A., Furlan M., Rha K.H., Almujalhem A., Derweesh I., Bradshaw A., Kaouk J., Sawczyn G., Bertolo R., Breda A., Montorsi F., Capitanio U., Larcher A.. The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery. European Urology Open Science. 2023; 49DOI:10.1016/j.euros.2022.12.017. PMID:36874602. IF:3.200(Q1/2D).
01/01/2023
Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial
Angulo J.C., Álvarez-Ossorio J.L., Domínguez-Escrig J.L., Moyano J.L., Sousa A., Fernández J.M., Gómez-Veiga F., Unda M., Carballido J., Carrero V., Fernandez-Aparicio T., García de Jalón Á., Solsona E., Inman B., Palou J.. Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial. European Urology Oncology. 2023; 6(1)DOI:10.1016/j.euo.2022.10.008. PMID:36435738. IF:8.300(Q1/1D).
01/01/2023
Management of renal cell carcinoma in transplant kidney: a systematic review and meta-analysis
Crocerossa F., Autorino R., Derweesh I., Carbonara U., Cantiello F., Damiano R., Rubio-Briones J., Roupret M., Breda A., Volpe A., Mir M.C., European Section of Urologic-Oncology (ESOU) of European Association of Urology. Management of renal cell carcinoma in transplant kidney: a systematic review and meta-analysis. Minerva Urology And Nephrology. 2023; 75(1)DOI:10.23736/S2724-6051.22.04881-9. PMID:36094386. IF:4.900(Q1/2D).
01/01/2023
Management of the incidental adrenal mass, continued surveillance versus surgical excision: analysis of US claims data on contemporary socio-demographic predictors and perioperative outcomes
Del Giudice F., Kim W., Li S., DE Berardinis E., Sciarra A., Salciccia S., Ferro M., Autorino R., Pandolfo S.D., Crocetto F., Galfano A., Dell'oglio P., Cacciamani G.E., Pradere B., Laukhtina E., D'Andrea D., Belladelli F., Krajewski W., Mari A., Minervini A., Gallioli A., Amparore D., Checcucci E., Fiori C., Porpiglia F., Morgantini L., Crivellaro S., Chung B.I.. Management of the incidental adrenal mass, continued surveillance versus surgical excision: analysis of US claims data on contemporary socio-demographic predictors and perioperative outcomes. Minerva Urology And Nephrology. 2023; 75(1)DOI:10.23736/S2724-6051.22.05073-X. PMID:36197701. IF:4.900(Q1/2D).
01/01/2023
Preliminary evaluation of infrared imaging for real-time graft reperfusion assessment during kidney transplant: an ESUT-YAUWP project
Veneziano D., Basile G., Cignoli D., Cozzupoli P., Sgrò E., Gomez Rivas J., Dourado A., Okhunov Z., Somani B., Territo A., Cacciamani G., Breda A.. Preliminary evaluation of infrared imaging for real-time graft reperfusion assessment during kidney transplant: an ESUT-YAUWP project. Minerva Urology And Nephrology. 2023; 75(1)DOI:10.23736/S2724-6051.22.05119-9. PMID:36282547. IF:4.900(Q1/2D).
01/01/2023
Implementing a Checklist for Transurethral Resection of Bladder Tumor to Standardize Outcome Reporting: When High-quality Resection Could Influence Oncological Outcomes
Diana P., Baboudjian M., Gallioli A., Territo A., Fontanet S., Izquierdo P., Uleri A., Verri P., Rodriguez-Faba Ó., Gaya J.M., Sanguedolce F., Palou J., Breda A.. Implementing a Checklist for Transurethral Resection of Bladder Tumor to Standardize Outcome Reporting: When High-quality Resection Could Influence Oncological Outcomes. European Urology Open Science. 2023; 48DOI:10.1016/j.euros.2022.09.025. PMID:36588772. IF:3.200(Q1/2D).